gression.8 3 In both studies the arteriograms were reviewed however, begins early in life1 2 and is well advanced by the by independent investigators and the criteria for diagnosing time the patient presents with symptoms of myocardial progression were clearly defined in advance. When the groups ischaemia. The silent progression of coronary arterial stenosis whose coronary artery disease progressed were compared with in apparently healthy men is a phenomenon about which we those whose disease remained static there were no significant know all too little. differences in family history, sex, blood pressure, smoking The coronary arteries may be visualised by arteriography, a habits, or serum lipid concentrations. The longer the interval technique introduced by Sones in 1962.3 During the past two between arteriograms the greater the chance of detecting decades coronary arteriography has proved a safe and inprogression, but the only clinical change that correlated with valuable procedure,4 being the only reliable method of progression during the interval was myocardial infarction; detecting coronary artery disease, and the best method of even so, 27-35% of those with proved infarction had unpredicting the outcome since the prognosis depends on the site changed coronary arteriograms. Age had little effect; the and extent of the disease.5 The procedure plays such an suggestion that progression was more frequent in younger important part in the management of coronary artery disease patients was discounted because they had had longer intervals that some patients have had it more than once. From these between their arteriograms. The more severe lesions seen on studies we can learn something about the progression of the first arteriograms seemed more likely to progress, and there coronary artery disease.
was a hint that progression might occur in bouts. The information has to be interpreted with caution for Regression was also seen, but only in 4-7% of patients.8 several reasons, including procedural differences among Coronary artery disease may undoubtedly regress6 -and this studies; observer error; the pitfalls of coronary arteriography6 has been reported in 32 patients so far.17 The most convincing and its occasional lack of correlation with necropsy findings 7; evidence comes from a patient whose single severe lesion of the the uncertain part played by coronary vasospasm; and, most left anterior descending coronary artery regressed, according important, the bias introduced by studying a selected populato the arteriograms, over 10 months; during this time he lost tion. The indications for repeating a coronary arteriogram are his angina pectoris, the findings of stress electrocardiography varied, but they include a change in the patient's condition, and thallium-201 myocardial imaging reverted to normal, and the advent of new forms of treatment, and-for example, in the collateral vessels disappeared. The patient had previously the Netherlands8-a long wait for surgical treatment. Inevit-given up smoking, and he adjusted his life style during the 10 ably many patients are excluded by death and this introduces months to bring about a fall in his serum lipid concentrations. a further bias. Despite these provisos we may draw some
In another study, on 25 patients who had optimal medical conclusions. The first is that adult patients with normal treatment for a year after an episode of unstable angina coronary arteriograms seldom, if ever, develop disease.9-11 pectoris, coronary artery disease regressed in five.'7 Secondly, about half the patients with coronary artery disease So arteriography is teaching us more about the progression will show progression of disease if arteriography is done two and regression of coronary artery disease but we are left with to three years later.8 12 13 Thirdly, the correlation between many questions, and at present we can detect a change in the progression and patients' risk factors or clinical state is surcoronary artery anatomy only by repeating the arteriogram. prisingly poor.8 ':
This has important implications. Patients who are being Two studies have shown a relation between arteriographic investigated with a view to coronary artery bypass grafting evidence of progression and hyperlipidaemia,'i 14 and one also should not have to wait more than a few months for surgical between progression and high blood pressure or cigarette treatment; otherwise they will need a repeat arteriogram smoking." This latter study may be unreliable because because their disease may have progressed and they may patients who had surgical treatment were included, and byrequire additional or more distal anastomoses. trimester and seven died, five with the fetus undelivered. Non-fulminant hepatitis in pregnancy did not, however, cause any increase in maternal or fetal loss. Both the incidence and severity of hepatitis in pregnancy vary widely around the world. In Western Europe and North America Sever and White2 found a low incidence of clinical hepatitis, one in 20 000. In another collective series3 a figure of one in 3000 was recorded for North America and Northern Europe, whereas in the Middle East, Africa, and India the reported incidence is around 30/. Findings similar to those from Kashmir have been reported from Iran by Borhanmanesh,4 who in a combined prospective and retrospective study of 61 pregnant women found that hepatitis developed much more frequently in the last trimester and that fulminant hepatic failure was also more frequent. Nevertheless, the lack of a standard definition of fulminant hepatic failure means that results from different trials must be interpreted with caution.
The reported effects of hepatitis on the course and outcome of pregnancy show a similar worldwide variation, and there are important differences between the Iranian and Indian studies. In Iran premature delivery or fetal death occurred in half of the cases of non-fulminant hepatitis, and in only one case of the 29 with fulminant hepatic failure did pregnancy continue. In contrast, non-fulminant hepatitis in Kashmir did not have any important influence on the course of pregnancy, and fetal loss in fatal fulminant hepatic failure was as a direct result of the mother's death. In a prospective study in North America Siegel et ala failed to show an increase in congenital abnormality or fetal mortality after non-fulminant hepatitis. Similar findings have been reported by Hieber et al,6 whose retrospective analysis found no increase in congenital malformation, stillbirth, abortion, or intrauterine malnutrition, though the incidence of prematurity was increased (270'). Earlier reports of an increase in Down's syndrome after hepatitis in pregnancy7 have not been substantiated in several carefully controlled epidemiological studies.8
There is no evidence of transmission of hepatitis to the infant for hepatitis A or for non-A, non- When hepatitis develops in a pregnant woman (whether it is type A, type B, or non-A, non-B, as in the Indian outbreak) the pregnancy should be allowed to continue to term, provided that placental function is not impaired and hepatic function is stable. Signs of fetal distress, poor progress, or rapid deterioration in maternal condition are all indications for rapid delivery by caesarean section if necessary. If the hepatitis becomes fulminant prompt delivery by caesarean section is recommended to improve the chances of the mother's recovering. Deterioration in the maternal condition may, however, continue after delivery in some cases of fulminant hepatic failure
